Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Oct 22;3(6):889-892.
doi: 10.1016/j.xkme.2021.10.001. eCollection 2021 Nov-Dec.

Voclosporin for Lupus Nephritis: A #NephJC Editorial on AURORA

Bourne Auguste  1 , Jade Teakell  2 , Avinash Rao Ullur  1 , Joel M Topf  3 , Swapnil Hiremath  4
Affiliations
Editorial

Voclosporin for Lupus Nephritis: A #NephJC Editorial on AURORA

Bourne Auguste et al. Kidney Med. .
No abstract available

Keywords: #NephJC; AURORA; Twitter journal club; lupus nephritis; voclosporin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) A Twitter conversation covering the cost of voclosporin and it being quite high compared to existing calcineurin inhibitors. From https://twitter.com/gearoidmm/status/1356961327680430082?s=20. (B) A Twitter poll, where a plurality of respondents thought that they needed more data before using voclosporin, and that the major message of the trial was that lower doses of steroids could be used safely. From https://twitter.com/gearoidmm/status/1356961327680430082?s=20. (C) A Twitter discussion of the advantages of using multiple agents at low doses, with the opposite side of the coin being a greater patient concern of toxicity and pill burden. From https://twitter.com/alhkim/status/1407805140955013120?s=20.
See this image and copyright information in PMC

References

    1. Cojocaru M., Cojocaru I.M., Silosi I., Vrabie C.D. Manifestations of systemic lupus erythematosus. Maedica (Bucur) 2011;6(4):330–336. - PMC - PubMed
    1. Mahajan A., Amelio J., Gairy K., et al. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression. Lupus. 2020;29(9):1011–1020. - PMC - PubMed
    1. Houssiau F.A., Vasconcelos C., D’Cruz D., et al. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum. 2002;46(8):2121–2131. - PubMed
    1. Appel G.B., Contreras G., Dooley M.A., et al. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol. 2009;20(5):1103–1112. - PMC - PubMed
    1. Houssiau F.A., Vasconcelos C., D’Cruz D., et al. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis. 2010;69(1):61–64. - PubMed

Publication types

LinkOut - more resources